BellRing Brands (BRBR) Rises As Market Takes a Dip: Key Facts

Company Performance - BellRing Brands (BRBR) closed at $67.52, reflecting a +1.24% change from the previous day's closing price, outperforming the S&P 500's daily loss of 0.28% [1] - The stock has increased by 7.36% over the past month, surpassing the Medical sector's decline of 3.47% and the S&P 500's gain of 0.41% [1] Upcoming Earnings - The earnings report for BellRing Brands is anticipated on November 18, 2024, with an expected EPS of $0.49, indicating a growth of 19.51% compared to the same quarter last year [2] - Revenue is projected to be $540.84 million, representing a 14.44% increase from the prior-year quarter [2] Analyst Estimates - Recent adjustments to analyst estimates for BellRing Brands indicate a favorable outlook on the company's business health and profitability [3] - The Zacks Consensus EPS estimate has increased by 0.3% over the past month, and the company currently holds a Zacks Rank of 2 (Buy) [5] Valuation Metrics - BellRing Brands has a Forward P/E ratio of 32.12, which is higher than the industry average of 23.76 [6] - The company has a PEG ratio of 1.56, compared to the Medical - Products industry's average PEG ratio of 1.88 [6] Industry Context - The Medical - Products industry, part of the Medical sector, has a Zacks Industry Rank of 74, placing it in the top 30% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]